Publisher’s note: The advice in this consensus is now out of date. Please see updated joint guidance from PCDS and ABCD, available here.
The PDF of this publication remains online for archival purposes. Please refer to the current version for up-to-date recommendations.
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
SGLT2 inhibitors show greater cardiovascular effects in older versus young people, whilst GLP-1 RAs are more effective in younger people.
1 May 2025